CU Anschutz announces $200M investment to launch cell, gene therapies institute

“The Gates Institute will make it possible for our faculty to achieve the vast potential of cell and gene therapies,” John J. Reilly Jr., the dean of the University of Colorado School of Medicine and vice chancellor for health affairs at CU Anschutz, said in a statement. The new institute will build upon work from two other Gates efforts, a center for regenerative medicine and a biomanufacturing facility, according to the university. Reilly said CU Anschutz "will build on that foundation so our scientists can develop a new generation of therapies that allow our clinicians to offer hope to those facing serious disease.”